Tag: global pharmaceutical companies

March 13, 2018

“China Will Become the Biggest Oncology Market in the World Over the Next 20 Years,” Says Chi-Med CEO Christian Hogg

Chi-Med, a China-based biopharmaceutical company, is making a name for itself within the oncology field at a global scale.
April 10, 2017

Five Prime Completes Enrollment of Phase 2 Trial

Five Prime Therapeutics finished enrollment for an ongoing Phase 2 trial of Cabiralizumab treating Pigmented Villonodular Synovitis.
January 19, 2017

Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology

Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced an exclusive license agreement with Stanford...
December 14, 2016

Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan)

Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting...
November 14, 2016

Thermo Fisher Scientific Submits Premarket Approval Application to FDA for Next-Generation Sequencing-Based Oncology Test

Thermo Fisher Scientific today reports it has submitted a premarket approval application to the FDA concerning its Oncomine Universal Dx...
October 24, 2016

Aduro Biotech to Host Conference Call

Aduro Biotech today announced that it will hold a conference call to provide a corporate update tomorrow, October 24, 2016,...
June 9, 2016

Aduro Biotech to Present at NASDAQ Investor Conference

June 09, 2016 08:00 ET | Source:Aduro Biotech, Inc. BERKELEY, Calif., June 09, 2016 (GLOBE NEWSWIRE) — Aduro Biotech, Inc....